GlassScriptPhysician profile
Brandy M Miles
NPI 1760664817
$10,199.14
in general payments reported to CMS, 2019-2025
41 companies · $3,414 in 2025
The $3,414 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,351 · 2022: $996 · 2023: $2,247 · 2024: $2,191 · 2025: $3,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,036 · Travel and Lodging: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,035.59 |
| Travel and Lodging | $816.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,539.37 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $1,256.67 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,068.85 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Inspire Medical Systems, INC. | $982.03 | 2023-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $616.84 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $539.69 | 2022-2025 | Dupixent |
| Genzyme Corporation | $517.67 | 2021-2025 | |
| Insmed, INC. | $501.72 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $501.61 | 2022-2025 | Tezspire, Tavneos |
| Mylan Specialty L.P. | $455.39 | 2022-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $268.40 | 2021-2025 | |
| United Therapeutics Corporation | $236.10 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Viatris Specialty LLC | $165.44 | 2025 | Yupelri |
| Verona Pharma, INC. | $149.28 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $147.37 | 2022-2025 | Winrevair, Dificid, Recarbrio |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $139.70 | 2021-2025 | Xolair |
| Axsome Therapeutics, INC. | $131.71 | 2023-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $131.34 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $97.92 | 2022-2023 | Acthar |
| Paratek Pharmaceuticals, INC. | $90.15 | 2022-2023 | Nuzyra |
| Philips North America LLC | $85.95 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Avadel Cns Pharmaceuticals, LLC | $84.63 | 2025 | Lumryz |
| Baxter Healthcare | $72.99 | 2023 | Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $50.50 | 2025 | Smartvest |
| Abbvie INC. | $43.79 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $41.91 | 2022-2023 | |
| Chiesi USA, INC. | $32.61 | 2021 | |
| Alexion Pharmaceuticals, INC. | $24.51 | 2022 | |
| Breas Medical, INC. | $24.17 | 2024 | Vivo 45 Ls |
| Ani Pharmaceuticals, INC. | $21.43 | 2024 | Purified Cortrophin Gel |
| Itamar Medical INC | $20.55 | 2023 | Watchpatone |
| Lilly USA, LLC | $19.04 | 2025 | Zepbound |
| 3b Medical, INC. | $18.97 | 2024 | Luna |
| Aimmune Therapeutics, INC. | $17.59 | 2025 | Zenpep |
| Resmed Corp | $16.69 | 2025 | |
| Sunovion Pharmaceuticals INC. | $16.09 | 2021 | |
| Advanced Respiratory, INC | $15.33 | 2021 | |
| Vifor Pharma, INC. | $14.67 | 2025 | Zemaira |
| Teva Pharmaceuticals USA, INC. | $14.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.83 | 2021 | |
| Grifols USA, LLC | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.